Dole plc Reports First Quarter 2025 Financial Results
- Biohaven Ltd. Reported its first quarter financial results for the period ending March 31, 2025, highlighting ongoing clinical and operational progress.
- In April 2025, the Company secured an investment arrangement with Oberland Capital valued at up to $600 million to fund the advancement of development and commercialization initiatives across five strategic platforms.
- Biohaven aims to complete three Phase 1 studies of degrader molecules and expects pivotal data in 1H 2025 for troriluzole in obsessive-compulsive disorder and in 2H 2025 for BHV-7000 in major depressive disorder.
- For the first quarter of 2025, the company reported a net loss of $221.7 million, equivalent to $2.17 per share, which is a decline from the $179.5 million net loss, or $2.20 per share, recorded in the same quarter of 2024.
- Biohaven's progress in clinical programs and secured financing position it to potentially achieve key milestones in 2025 and 2026, though forward-looking statements involve uncertainties and risks.
83 Articles
83 Articles


Peyto Reports First Quarter 2025 Results
CALGARY, Alberta, May 13, 2025 (GLOBE NEWSWIRE) -- Peyto Exploration & Development Corp. (TSX: PEY) ("Peyto" or the "Company") is pleased to report operating and financial results for the first quarter of 2025.
Intuitive Machines Reports First Quarter 2025 Financial Results
HOUSTON, May 13, 2025 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR, “Intuitive Machines,” or the “Company”), a leading space technology and infrastructure services company, today announced its financial results for the first quarter ended March 31, 2025.
Ravelin Properties REIT Reports First Quarter 2025 Results
TORONTO, May 12, 2025 /CNW/ - Ravelin Properties REIT (TSX:RPR) ("Ravelin" or the "REIT"), an internally managed global owner and operator of well-located commercial real estate, announces financial results for the three months ended March 31, 2025. The REIT's unaudited interim financial statements and Management's Discussion and Analysis for the three months ended March 31, 2025 are available under the REIT's issuer profile on SEDAR+ and can al…
Coverage Details
Bias Distribution
- 51% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage